1. Evaluation of clinical trial eligibility and prognostic indices in a population‐based cohort of systemic peripheral T‐cell lymphomas from the Danish Lymphoma Registry
   Martin Bjerregaard Pedersen et al, 2015, Hematological Oncology CrossRef
2. Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma
   Daisuke Kurita et al, 2015, International Journal of Hematology CrossRef
3. Pirarubicin‐based intensive chemotherapy followed by consolidative high‐dose chemotherapies for peripheral T‐cell lymphomas: A noncomparative phase 2 study
   Hiromichi Takahashi et al, 2022, Hematological Oncology CrossRef
4. Role of upfront autologous transplant for peripheral T-cell lymphoma patients achieving a complete remission with first-line therapy: a systematic review and meta-analysis
   L. Girard et al, 2024, Bone Marrow Transplantation CrossRef
5. Topotecan combined with Ifosfamide, Etoposide, and l-asparaginase (TIEL) regimen improves outcomes in aggressive T-cell lymphoma
   YaJuan Shao et al, 2015, Medical Oncology CrossRef
6. Hematopoietic Stem Cell Transplantation in Lymphomas: including our hospital experience
   Hiromichi Takahashi et al, 2015, Journal of Nihon University Medical Association CrossRef